Compare · AAON vs TMO
AAON vs TMO
Side-by-side comparison of AAON Inc. (AAON) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AAON and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $242.77B, about 33.4x AAON ($7.26B).
- TMO has been more active in the news (7 items in the past 4 weeks vs 1 for AAON).
- TMO has more recent analyst coverage (25 ratings vs 12 for AAON).
- Company
- AAON Inc.
- Thermo Fisher Scientific Inc
- Price
- $87.17-1.02%
- $661.78+0.75%
- Market cap
- $7.26B
- $242.77B
- 1M return
- -
- +9.72%
- 1Y return
- -
- +23.37%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 1
- 7
- Recent ratings
- 12
- 25
AAON Inc.
AAON, Inc., together with its subsidiaries, engages in engineering, manufacturing, marketing, and selling air conditioning and heating equipment in the United States and Canada. It offers rooftop units, chillers, packaged outdoor mechanical rooms, air handling units, makeup air units, energy recovery units, condensing units, geothermal/water-source heat pumps, self-contained units, coils, and controls. The company markets and sells its products to retail, manufacturing, educational, lodging, supermarket, medical, and other commercial industries. It sells its products through a network of manufacturers' representatives and internal sales force. The company was incorporated in 1987 and is based in Tulsa, Oklahoma.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest AAON
- Director Stewart David Raymond bought $74,660 worth of shares (1,000 units at $74.66) (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by AAON Inc.
- Director Asbjornson Norman H gifted 100,000 shares (SEC Form 4)
- Director Jermain Patrick John was granted 1,284 shares (SEC Form 4)
- Director Buttermore Robert L. was granted 1,284 shares (SEC Form 4)
- Executive Vice President Shaub Matthew bought $34,924 worth of shares (457 units at $76.42), increasing direct ownership by 17% to 3,136 units (SEC Form 4)
- AAON Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- AAON Introduces The Aaon Group as Its New Enterprise Identity
- AAON Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- AAON Announces Quarterly Cash Dividend
Latest TMO
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- SEC Form 4 filed by Director Keith R. Alexandra
- Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026
- Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development
- Thermo Fisher upgraded by UBS with a new price target
- CLSA initiated coverage on Thermo Fisher with a new price target
- Executive Vice President Shafer Michael D covered exercise/tax liability with 790 shares, decreasing direct ownership by 4% to 20,204 units (SEC Form 4)